APA (7th ed.) Citation

T, P., F, G., S, V., A, P., I, B., A, S., . . . F, F. (2026). Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic Value. Clinical endocrinology, 104(6), 670. https://doi.org/10.1111/cen.70113

Chicago Style (17th ed.) Citation

T, Piticchio, et al. "Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic Value." Clinical Endocrinology 104, no. 6 (2026): 670. https://doi.org/10.1111/cen.70113.

MLA (9th ed.) Citation

T, Piticchio, et al. "Pre-RAI Monocyte-to-Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate-Risk DTC, While PNI and NRI Show No Prognostic Value." Clinical Endocrinology, vol. 104, no. 6, 2026, p. 670, https://doi.org/10.1111/cen.70113.